Skip to main content
Top
Published in: Annals of Surgical Oncology 10/2015

Open Access 01-10-2015 | Breast Oncology

Oncoplastic Split Reduction with Intraoperative Radiation Therapy

Authors: Melvin J. Silverstein, MD, Nirav B. Savalia, MD, Sadia Khan, DO, Jessica Ryan, MD, Melinda Epstein, PhD, Cristina DeLeon, RN, BSN, Peter Chen, MD, Brian Kim, MD

Published in: Annals of Surgical Oncology | Issue 10/2015

Login to get access

Excerpt

A standard Wise-pattern reduction can be used to excise a breast cancer that falls within the Wise pattern.1 When the tumor is located outside the Wise pattern, it can be removed by tunneling and pulling the lesion through the Wise-pattern incision. When it is necessary to take skin overlying the tumor, the Wise pattern can be reconfigured by moving either the lower inner or lower outer quadrant triangles, which are a normal part of the standard Wise pattern, to a position over the tumor. This change must be accompanied by splitting the vertical limb of the reduction to accommodate the repositioning of the triangle, a technique known as split reduction.2 This alteration in the Wise pattern removes the skin directly over the tumor and guarantees that the anterior margin will be clear. …
Appendix
Available only for authorised users
Literature
1.
go back to reference Silverstein MJ, Mai T, Savalia N, Vaince F, Guerra L. Oncoplastic breast conservation surgery: the new paradigm. J Surg Oncol. 2014;110:82–9.CrossRefPubMed Silverstein MJ, Mai T, Savalia N, Vaince F, Guerra L. Oncoplastic breast conservation surgery: the new paradigm. J Surg Oncol. 2014;110:82–9.CrossRefPubMed
2.
3.
go back to reference Vaidya J, Wenz F, Bulsara M, et al. Risk-adapted targited intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet. 2014;383:603–13.CrossRefPubMed Vaidya J, Wenz F, Bulsara M, et al. Risk-adapted targited intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet. 2014;383:603–13.CrossRefPubMed
4.
go back to reference Veronesi U, Orecchia R, Maisinneuve P, et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol. 2013;14:1269–77.CrossRefPubMed Veronesi U, Orecchia R, Maisinneuve P, et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol. 2013;14:1269–77.CrossRefPubMed
Metadata
Title
Oncoplastic Split Reduction with Intraoperative Radiation Therapy
Authors
Melvin J. Silverstein, MD
Nirav B. Savalia, MD
Sadia Khan, DO
Jessica Ryan, MD
Melinda Epstein, PhD
Cristina DeLeon, RN, BSN
Peter Chen, MD
Brian Kim, MD
Publication date
01-10-2015
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 10/2015
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-4671-4

Other articles of this Issue 10/2015

Annals of Surgical Oncology 10/2015 Go to the issue